Oncology
Advanced Solid Cancer
0
Pipeline Programs↗
1
Active Trials↗
8
Companies Involved↗
Advanced Solid Cancer is an early-stage landscape with 0 programs across 8 companies. The most active players are Samyang Biopharmaceuticals Corporation, Tianjin Hemay Pharmaceutical Co., Ltd, Shanghai Hengrui Pharmaceutical Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Completed7 · 50%
Terminated4 · 29%
Unknown status2 · 14%
Active, not recruiting1 · 7%
Clinical Trials
Trial Activity
14 trials
Phase I Study of TENPA in Advanced Solid Cancer
Terminated·—·Phase 1·NCT02979392·19 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)